Can thrombolytics prevent post-phlebitic syndrome and thrombo-embolic disease?
D000293:Adolescent; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D010690:Phlebography; D010958:Plasminogen / Q000378:metabolism; D011186:Postphlebitic Syndrome / Q000517:prevention & control*; D013300:Streptokinase / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*; D000979:alpha-2-Antiplasmin / Q000378:metabolism
D000979:alpha-2-Antiplasmin; D005340:Fibrinogen; D010958:Plasminogen; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator